Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 334


Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?

Lee KG, Lee HJ, Oh SY, Yang JY, Ahn HS, Suh YS, Kong SH, Kim TY, Oh DY, Im SA, Lee KU, Kim WH, Bang YJ, Yang HK.

Ann Surg Oncol. 2015 Nov 23. [Epub ahead of print]


Salvaging the Exposed Cochlear Implant.

Seo BF, Park SW, Han HH, Moon SH, Oh DY, Rhie JW.

J Craniofac Surg. 2015 Nov;26(8):e749-52. doi: 10.1097/SCS.0000000000002259.


Phase II trial of dacomitinib in patients with HER2-positive gastric cancer.

Oh DY, Lee KW, Cho JY, Kang WK, Im SA, Kim JW, Bang YJ.

Gastric Cancer. 2015 Nov 18. [Epub ahead of print]


Genome-wide Association Study to Identify Quantitative Trait Loci for Meat and Carcass Quality Traits in Berkshire.

Iqbal A, Kim YS, Kang JM, Lee YM, Rai R, Jung JH, Oh DY, Nam KC, Lee HK, Kim JJ.

Asian-Australas J Anim Sci. 2015 Nov;28(11):1537-1544.


Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.

Kim H, Youk J, Yang Y, Kim TY, Min A, Ham HS, Cho S, Lee KH, Keam B, Han SW, Oh DY, Ryu HS, Han W, Park IA, Kim TY, Noh DY, Im SA.

J Cancer Res Clin Oncol. 2015 Nov 18. [Epub ahead of print]


Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study.

Choi Y, Oh DY, Kim K, Chie EK, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Ha SW, Bang YJ.

Cancer Res Treat. 2015 Oct 16. doi: 10.4143/crt.2015.226. [Epub ahead of print]


Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma.

Lee KH, Lee KB, Kim TY, Han SW, Oh DY, Im SA, Kim TY, Yi NJ, Lee KW, Suh KS, Jang JJ, Bang YJ.

BMC Cancer. 2015 Oct 16;15:721. doi: 10.1186/s12885-015-1737-4.


Capecitabine for the treatment of gastric cancer.

Kim TY, Oh DY, Bang YJ.

Expert Rev Gastroenterol Hepatol. 2015 Oct 15:1-11. [Epub ahead of print]


Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients.

Lee DW, Han SW, Cha Y, Lee KH, Kim TY, Oh DY, Im SA, Bang YJ, Park JW, Ryoo SB, Jeong SY, Kang GH, Park KJ, Kim TY.

BMC Cancer. 2015 Oct 14;15:690. doi: 10.1186/s12885-015-1704-0.


Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?

Park HJ, Kim K, Paik JH, Chie EK, Kim S, Jang JY, Kim SW, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW.

Clin Transl Oncol. 2015 Oct 12. [Epub ahead of print]


Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.

Choi Y, Oh DY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ.

PLoS One. 2015 Oct 5;10(10):e0139749. doi: 10.1371/journal.pone.0139749. eCollection 2015.


HER2 as a novel therapeutic target for cervical cancer.

Oh DY, Kim S, Choi YL, Cho YJ, Oh E, Choi JJ, Jung K, Song JY, Ahn SE, Kim BG, Bae DS, Park WY, Lee JW, Song S.

Oncotarget. 2015 Nov 3;6(34):36219-30. doi: 10.18632/oncotarget.5283.


Capsular Contracture after Calf Augmentation with Silicone Implant Insertion.

Seo BF, Choi JY, Kim J, Oh DY.

Arch Plast Surg. 2015 Sep;42(5):642-5. doi: 10.5999/aps.2015.42.5.642. Epub 2015 Sep 15. No abstract available.


A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.

Lee KH, Kim JY, Lee MH, Han HS, Lim JH, Park KU, Park IH, Cho EK, Yoon SY, Kim JH, Choi IS, Park JH, Choi YJ, Kim HJ, Jung KH, Kim SY, Oh DY, Im SA.

Support Care Cancer. 2015 Oct 1. [Epub ahead of print]


Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial.

Bianchini G, Pusztai L, Pienkowski T, Im YH, Bianchi GV, Tseng LM, Liu MC, Lluch A, Galeota E, Magazzù D, de la Haba-Rodríguez J, Oh DY, Poirier B, Pedrini JL, Semiglazov V, Valagussa P, Gianni L.

Ann Oncol. 2015 Sep 19. pii: mdv395. [Epub ahead of print]


On the Verge: Immunotherapy for Colorectal Carcinoma.

Oh DY, Venook AP, Fong L.

J Natl Compr Canc Netw. 2015 Aug;13(8):970-8. Review.


Treatment of mallet fracture using a percutaneous fixation technique with an 18-gauge needle.

Rha Ey, Lee Mc, Lee Jh, Moon Sh, Rhie Jw, Oh Dy.

Acta Orthop Belg. 2015 Jun;81(2):296-302.


The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer.

Kim BH, Kim K, Chie EK, Kwon J, Jang JY, Kim SW, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW.

J Gastrointest Surg. 2015 Oct;19(10):1833-41. doi: 10.1007/s11605-015-2898-9. Epub 2015 Aug 4.


High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy.

Lim YJ, Koh J, Kim K, Chie EK, Kim B, Lee KB, Jang JY, Kim SW, Oh DY, Bang YJ, Ha SW.

Radiother Oncol. 2015 Oct;117(1):165-70. doi: 10.1016/j.radonc.2015.07.003. Epub 2015 Jul 30.


Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX.

Lee DW, Han SW, Cha Y, Rhee YY, Bae JM, Cho NY, Lee KH, Kim TY, Oh DY, Im SA, Bang YJ, Jeong SY, Park KJ, Kang GH, Kim TY.

Clin Epigenetics. 2015 Jul 9;7(1):63. doi: 10.1186/s13148-015-0106-0. eCollection 2015.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk